Demant AS
DEMANT: XCSE (DNK)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| s<Z | LOCK|V?^@m | LOCK|>@NY^> |
Demant Earnings: Macroeconomic Uncertainty Continues to Weigh on Market Growth; Shares Undervalued
Demant reported third-quarter earnings with 3% organic sales growth, driven by a 4% increase in Hearing Care, despite a weak global hearing healthcare market caused by macroeconomic uncertainty. Management reiterated full-year guidance, emphasizing a higher likelihood for the lower end.
